132 related articles for article (PubMed ID: 4716799)
1. Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide.
Grantham PH; Weisburger JH; Weisburger EK
Food Cosmet Toxicol; 1973 Apr; 11(2):209-17. PubMed ID: 4716799
[No Abstract] [Full Text] [Related]
2. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats.
Ulland BM; Weisburger JH; Yamamoto RS; Weisburger EK
Food Cosmet Toxicol; 1973 Apr; 11(2):199-207. PubMed ID: 4352030
[No Abstract] [Full Text] [Related]
3. Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid.
Matsushima T; Grantham PH; Weisburger EK; Weisburger JH
Biochem Pharmacol; 1972 Aug; 21(15):2043-51. PubMed ID: 4645881
[No Abstract] [Full Text] [Related]
4. Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats.
Weisburger JH; Grantham PH; Horton RE; Weisburger EK
Biochem Pharmacol; 1970 Jan; 19(1):151-62. PubMed ID: 5507633
[No Abstract] [Full Text] [Related]
5. Metabolism of the carcinogen N-2-fluorenylacetamide in germ-free and conventional rats.
Grantham PH; Horton RE; Weisburger EK; Weisburger JH
Biochem Pharmacol; 1970 Jan; 19(1):163-71. PubMed ID: 5507634
[No Abstract] [Full Text] [Related]
6. Further evidence for two types of adducts of N-hydroxy-2-fluorenylacetamide with rat-liver proteins.
Barry EJ; Gutmann HR
Chem Biol Interact; 1970 Aug; 2(2):158-9. PubMed ID: 5526729
[No Abstract] [Full Text] [Related]
7. Effect of carbon monoxide or of 3-aminotriazole on C-and N-hydroxylation of the carcinogen N-2-fluorenylacetamide by liver microsomes of hamsters pretreated with 3-methylcholanthrene.
Matsushima T; Weisburger JH
Xenobiotica; 1972 Sep; 2(5):423-30. PubMed ID: 4649039
[No Abstract] [Full Text] [Related]
8. Chromatographic separation of the urinary metabolites of the carcinogen N-2-fluorenylacetamide into free compounds, sulfuric acid, and glucuronic acid esters.
WEISBURGER JH; GRANTHAM PH; MORRIS HP; WEISBURGER EK
Cancer Res; 1961 Aug; 21():949-55. PubMed ID: 13784010
[No Abstract] [Full Text] [Related]
9. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
[No Abstract] [Full Text] [Related]
10. Metabolic activation of N-hydroxy compounds by conjugation.
Irving CC
Xenobiotica; 1971; 1(4):387-98. PubMed ID: 5006106
[No Abstract] [Full Text] [Related]
11. DIFFERENCES IN THE METABOLISM OF N-HYDROXY-N-2-FLUORENYLACETAMIDE IN MALE AND FEMALE RATS.
WEISBURGER EK; GRANTHAM PH; WEISBURGER JH
Biochemistry; 1964 Jun; 3():808-12. PubMed ID: 14211620
[No Abstract] [Full Text] [Related]
12. The carinogenicity of N-hydroxy-N-2-fluorenyl-acetamide and the matabolism of N-2-fluorenyl-acetamide in Praomis (mastomys) natalensis.
Yamamoto RS; Pai SR; Korzis J; Weisburger JH
Br J Cancer; 1968 Dec; 22(4):769-75. PubMed ID: 4303104
[No Abstract] [Full Text] [Related]
13. Studies on the mechanism of inhibition of 2-acetylaminofluorene toxicity by butylated hydroxytoluene.
Goodman JI; Trosko JE; Yager JD
Chem Biol Interact; 1976 Feb; 12(2):171-82. PubMed ID: 1248061
[TBL] [Abstract][Full Text] [Related]
14. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
Witschi H; Epstein SM; Farber E
Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
[No Abstract] [Full Text] [Related]
15. Inhibitors of chemical carcinogens as probes for molecular targets: DNA as decisive receptor for metabolite from N-hydroxy-N-2-fluorenylacetamide.
Matsushima T; Weisburger JH
Chem Biol Interact; 1969 Dec; 1(2):211-21. PubMed ID: 5407060
[No Abstract] [Full Text] [Related]
16. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat.
Chung JG
Toxicol Sci; 1999 Oct; 51(2):202-10. PubMed ID: 10543022
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide.
Levine WG
Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052
[No Abstract] [Full Text] [Related]
18. Effects of adrenocorticotropic hormone and growth hormone on the metabolism of N-hydroxy-N-2-fluorenylacetamide and on physiologic parameters.
Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
Cancer Res; 1967 Jan; 27(1):81-7. PubMed ID: 4289799
[No Abstract] [Full Text] [Related]
19. Interaction of aromatic amines with rat-liver proteins in vivo. 3. On the mechanism of binding of the carcinogens, N-2-fluorenylacetamide and N-hydroxy-2-fluorenyl-acetamide, to the soluble proteins.
Barry EJ; Malejka-Giganti D; Gutmann HR
Chem Biol Interact; 1969 Dec; 1(2):139-55. PubMed ID: 5407058
[No Abstract] [Full Text] [Related]
20. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
Yost Y; Gutmann HR; Rydell RE
Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
